ITF-Labomed Farmacéutica

What ITF-Labomed Farmacéutica does

ITF-Labomed Farmacéutica Ltda. is a Chilean pharmaceutical company, established circa 2000 as a subsidiary of Italian multinational Grupo Italfarmaco (founded 1938). Headquartered in Las Condes, Santiago, the company develops, manufactures, and commercializes pharmaceutical products across ten therapeutic divisions: Cardiovascular, Dermatological, Women's Health, Neurosciences, Nutraceuticals, Ophthalmological, Osteoarticular, Pediatric, Respiratory, and Urological. Operations are supported by manufacturing facilities operating under Good Manufacturing Practices (GMP) and Good Storage and Distribution Practices (GDP), together with an in-house pharmacovigilance system aligned to Chilean health authority requirements. The company employs between 101 and 250 people.

The business model is a sales-led, channel-distributed pharmaceutical operation. ITF-Labomed reaches healthcare professionals through a medical-representative salesforce and physician-targeted webinars, while finished products reach patients via Chile's five principal retail pharmacy chains: Cruz Verde, Salcobrand, Farmacias Ahumada, Profar, and Farmaloop. Pricing is not publicly disclosed and certain products are prescription-only. The company also maintains a consumer/digital presence (corporate website, Facebook, LinkedIn, Instagram, YouTube) and runs health-awareness campaigns (e.g., on acute respiratory infections). Recent product activity includes the promotion of ZARELIS BO and the nutraceutical ERGOSEL Omega-3 + Vitaminas del Complejo B.

ITF-Labomed operates exclusively within Chile and functions as Grupo Italfarmaco's regional entity, drawing on the parent group's international pharmaceutical standards, R&D, and governance frameworks. The company is privately held as a limitada (Ltda.) with no public listing, no disclosed external investors, and no disclosed funding rounds. Financial figures including revenue are not publicly reported.

Name

ITF-Labomed Farmacéutica

Legal name

ITF-Labomed Farmacéutica Ltda.

Website

https://itf-labomed.cl

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

ITF-Labomed Farmacéutica is a Chilean pharmaceutical subsidiary of Italy's Grupo Italfarmaco that manufactures and distributes medications across ten therapeutic areas through medical representatives and Chile's major pharmacy chains.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYHLAIAAAI

Gastroenterology & Hepatology Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYAFAKAJAC

Medical Foods Manufacturing (Disease-Specific, Clinically Supervised)

Agriculture & Food Production/Food Processing & Manufacturing/Specialty & Functional Foods Manufacturing (Organic, Fortified, Medical Foods)

Keywords

• Pharmaceutical manufacturing
• Prescription medications
• Therapeutic divisions
• Nutraceutical supplements
• Pharmaceutical distribution

Headquarters

HQ city

Lampa

HQ country

Chile

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: ITF-Labomed develops and commercializes pharmaceutical products across multiple therapeutic divisions including Cardiovascular, Dermatological, Women's Health, Neurosciences, Nutraceuticals, Ophthalmological, Osteoarticular, Pediatric, Respiratory, and Urological. Products are distributed through pharmacy chains and prescribed by healthcare professionals.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels5 records

Core offering

ITF-Labomed Farmacéutica develops, manufactures, and commercializes pharmaceutical products across ten therapeutic divisions including Cardiovascular, Dermatological, Women's Health, Neurosciences, Nutraceuticals, Ophthalmological, Osteoarticular, Pediatric, Respiratory, and Urological. The company distributes its products in Chile through major pharmacy chains and promotes them to healthcare professionals via medical representatives and educational webinars.

Product overview

ITF-Labomed Farmacéutica is a Chilean pharmaceutical company that manufactures and distributes medications across 10 therapeutic divisions: Cardiovascular, Dermatological, Women's Health, Neurosciences, Nutraceuticals, Ophthalmological, Osteoarticular, Pediatric, Respiratory, and Urological. The company is part of the Italfarmaco Group (Italy, founded 1938) and produces pharmaceutical products distributed through major Chilean pharmacy chains including Cruz Verde, Salcobrand, Ahumada, Profar, and Farmaloop. Products include cardiovascular medications, dermatological treatments, women's health therapies, neurological medications, nutraceuticals, and various other pharmaceutical products.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiovascular Division

Named customers6 records

Segments10 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Grupo Italfarmaco (Italy)coreOthersITF-Labomed is a Chilean subsidiary and part of Grupo Italfarmaco, an Italian pharmaceutical company established in 1938. The parent company provides global resources, pharmaceutical expertise, and strategic direction for the Chilean operations. This relationship provides ITF-Labomed with international pharmaceutical standards, R&D capabilities, and corporate governance frameworks.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Laboratorios Andrómaco: Chilean pharmaceutical company specializing in dermatology and women's health, with branded products distributed via Chilean retail pharmacies. Comparable to ITF-Labomed's Dermatological and Women's Health divisions in product positioning and domestic-channel GTM.
• Eurofarma: Brazilian multinational pharmaceutical company with broad multi-therapeutic branded and OTC portfolio and a growing LatAm commercial footprint, including Chile. Comparable as a regional branded pharma operator competing for retail shelf space and prescriber attention in Latin America.
• Laboratorios Bagó (Chile): Argentine-founded multinational pharmaceutical group with multi-therapeutic branded portfolio and active Chilean operations selling through retail pharmacy chains. Highly comparable to ITF-Labomed in business model, therapeutic breadth, and retail-pharmacy-driven GTM across the same geography.
• Maver: Chilean pharmaceutical company distributing multi-therapeutic branded products through retail pharmacy networks. Comparable to ITF-Labomed as a domestic Chilean pharma operator focused on pharmacy-channel distribution.

Broad incumbents

• Bayer Chile: Chilean operations of global Bayer Group, selling a broad multi-therapeutic branded-pharma portfolio through retail pharmacies in Chile. Overlaps directly with ITF-Labomed's cardiovascular and women's health franchises and competes on shelf access.
• Sanofi Chile: Chilean operations of global pharmaceutical major Sanofi, with broad multi-therapeutic branded-pharma portfolio sold through Chilean retail pharmacies and medical channels. Overlaps with multiple ITF-Labomed divisions as a larger incumbent competitor.
• Teva Pharmaceutical Chile: Chilean arm of Teva, offering a multi-therapeutic branded and generic pharmaceutical portfolio distributed through retail pharmacies. Overlaps with ITF-Labomed in multi-therapeutic branded-pharma positioning with a broader generics backbone.
• Novartis Chile: Chilean operations of Novartis, distributing a broad branded-pharma portfolio including cardiovascular and ophthalmology products via Chilean pharmacy channels. Comparable in therapeutic breadth and retail-pharmacy-driven distribution model.
• Pfizer Chile: Chilean arm of Pfizer, with a large branded-pharma portfolio spanning cardiovascular, neurosciences, and other therapeutic areas. Competes with ITF-Labomed in several of its 10 divisions, with materially larger R&D and marketing resources.
• Roche Chile: Chilean operations of Roche, selling branded pharmaceuticals and diagnostics across multiple therapeutic areas including neurosciences and ophthalmology. Comparable as a multinational incumbent competing in several ITF-Labomed therapeutic divisions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@itflabomed2180
• Facebookfacebook.com/itflabomed
• LinkedInlinkedin.com/company/itf-labomed-farmaceutica-limitada
• Instagraminstagram.com/itflabomed
• Xx.com/ITFLabomed

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ITF-Labomed Farmacéutica